Skip to content
  • Saturday, 15 August 2026
  • 3:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease
Neuroscience & Brain Research

Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease

Rifan Muazin Jun 19, 2026 0

Researchers at the Institute for Neurosciences in Spain and the École Polytechnique Fédérale de Lausanne in Switzerland have announced the…

Read More
Neuroscience & Brain Research

Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment

Rifan Muazin Mar 19, 2026 0

Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…

Read More
DNA Aptamers Offer a Promising New Frontier in Identifying and Targeting Senescent Cells for Aging and Disease ResearchHow Medvi Built a $1.8 Billion Telehealth Empire in Regulatory Blind Spots: A Deep Dive into AI, Compounding, and Fragmented OversightScientists Replicate Human Bone Marrow Complexity in Laboratory Breakthrough Using Pluripotent Stem CellsSmall study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ